Table 2 Antiviral activity of different aptamers against SARS-CoV-2.
From: SELEX based aptamers with diagnostic and entry inhibitor therapeutic potential for SARS-CoV-2
Sample | Concentration (uM) | Ct value | Copy number/ml | % Inhibition |
|---|---|---|---|---|
Infection (0.1 MOI) | 25.398 | 43,621.18581 | ||
Aptamer R | 4 | 30.091 | 1994.156045 | 95.4 |
Aptamer T | 4 | 26.377 | 22,917.9018 | 47.4 |
Aptamer J | 8 | 28.080 | 7480.607116 | 82.5 |
Aptamer L | 8 | 26.885 | 16,410.86434 | 62.3 |
